[시장보고서]약물전달 시스템 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2035년)

약물전달 시스템 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2035년)

Drug Delivery Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

상품코드 : 1742536

리서치사 : Transparency Market Research

발행일 : 2025년 04월

페이지 정보 : 영문 187 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,795

￦ 8,598,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,795

￦ 13,049,000

PDF (Multi-user License)

PDF 보고서를 동일 부서 5명이 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy & Paste가 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 11,795

￦ 17,500,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

샘플 요청 목록에 추가

약물전달 시스템 시장 - 조사 범위

TMR의 조사 보고서 "세계 약물전달 시스템 시장"은 2025-2035년 예측 기간 동안 시장 지표에 대한 귀중한 인사이트를 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회를 조사하고 있습니다. 이 보고서는 2019년부터 2035년까지의 세계 약물전달 시스템 시장의 수익과 예측을 제공하는데, 2025년을 기준 연도로, 2035년을 예측 연도로 삼고 있습니다. 또한, 2025-2035년까지의 세계 약물전달 시스템 시장의 연평균 성장률(CAGR %)을 제시합니다.

이 보고서는 광범위한 조사를 통해 작성되었습니다. 1차 조사에서 애널리스트는 주요 오피니언 리더, 업계 리더, 오피니언 메이커를 대상으로 인터뷰를 진행했습니다. 2차 조사에서는 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 자료 등을 참고하여 약물전달 시스템 시장을 이해하고자 했습니다.

시장 현황
2024년 시장 규모	2,659억 달러
2035년 시장 규모	4,629억 달러
CAGR	5.1%

이 보고서는 세계 약물전달 시스템 시장의 경쟁 환경을 조사하고 있습니다. 세계 약물전달 시스템 시장에서 활동하는 주요 기업이 확인되었으며, 각 기업은 다양한 속성별로 프로파일링되어 있습니다. 회사 개요, 재무 상태, 최근 동향, SWOT는 세계 약물전달 시스템 시장 기업의 속성이며, 이 보고서에서 소개합니다.

소개와 정의
주요 조사 결과/진전
시장 금액 예측 : 유형별, 2020-2035년
- 경구 약물전달 시스템
  - 제어 방출 약물전달
  - 기타
- 주사 기반 약물전달 시스템
  - 주사 약물전달 시스템
  - 주사기
- 경피 약물전달 시스템
- 흡입 약물전달 시스템
- 이식형 약물전달 시스템
- 기타
시장 매력 : 유형별

제7장 세계의 시장 분석과 예측 : 용도별

소개와 정의
주요 조사 결과/진전
시장 금액 예측 : 용도별, 2020-2035년
- 종양성 질환
- 감염증
- 호흡기질환
- 심혈관질환
- 자가면역질환
- 중추신경계 질환
- 기타
시장 매력 : 용도별

제8장 세계의 시장 분석과 예측 : 최종사용자별

소개와 정의
주요 조사 결과/진전
시장 금액 예측 : 최종사용자별, 2020-2035년
- 병원
- 외래 수술 센터
- 재택 케어 설정
- 기타
시장 매력 : 최종사용자별

제9장 세계의 시장 분석과 예측 : 지역별

주요 조사 결과
시장 금액 예측 : 지역별
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
시장 매력 : 지역별

제10장 북미의 시장 분석과 예측

미국
캐나다

제11장 유럽의 시장 분석과 예측

독일
영국
프랑스
스페인
이탈리아
기타 유럽

제12장 아시아태평양의 시장 분석과 예측

중국
일본
인도
호주와 뉴질랜드
기타 아시아태평양

제13장 라틴아메리카의 시장 분석과 예측

브라질
멕시코
기타 라틴아메리카

제14장 중동 및 아프리카의 시장 분석과 예측

GCC 국가
남아프리카공화국
기타 중동 및 아프리카

제15장 경쟁 구도

시장 기업 - 경쟁 매트릭스(기업 계층별·규모별)
회사 시장 점유율 분석(2024)
기업 개요
- Becton, Dickinson and Company
- B. Braun Melsungen AG
- Terumo Medical Corporation
- Medtronic plc
- Koninklijke Philips N.V.
- Baxter International Inc.
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- Teleflex Incorporated
- Novartis AG
- Gerresheimer AG
- Abbott
- Ypsomed AG
- SHL Medical
- Owen Mumford

KSM

영문 목차

영문목차

Drug Delivery Systems Market - Scope of Report

TMR's report on the global drug delivery systems market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global drug delivery systems market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global drug delivery systems market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the drug delivery systems market.

Market Snapshot
Market Value in 2024	US$ 265.9 Bn
Market Value in 2035	US$ 462.9 Bn
CAGR	5.1%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global drug delivery systems market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global drug delivery systems market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global drug delivery systems market.

The report delves into the competitive landscape of the global drug delivery systems market. Key players operating in the global drug delivery systems market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global drug delivery systems market profiled in this report.

Key Questions Answered in global drug delivery systems Market Report:

What is the sales/revenue generated by drug delivery systems across all regions during the forecast period?
What are the opportunities in the global drug delivery systems market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2035?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

Drug Delivery Systems Market - Research Objectives and Research Approach

The comprehensive report on the global drug delivery systems market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global drug delivery systems market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global drug delivery systems market.

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Drug Delivery Systems Market

4. Market Overview

4.1. Introduction
- 4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. Global Drug Delivery Systems Market Analysis and Forecasts, 2020-2035
- 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

5.1. Healthcare Expenditure across Key Regions / Countries
5.2. Technological Advancements in Drug Delivery Systems
5.3. Regulatory Scenario across Key Regions / Countries
5.4. PORTER's Five Forces Analysis
5.5. PESTLE Analysis
5.6. Key Industry Events (Partnership, Collaborations, Product approvals, merger & acquisitions)

6. Global Drug Delivery Systems Market Analysis and Forecasts, By Type

6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Type, 2020-2035
- 6.3.1. Oral Drug Delivery System
  - 6.3.1.1. Controlled-release Drug Delivery
  - 6.3.1.2. Other Oral Drug Delivery
- 6.3.2. Injection-based Drug Delivery System
  - 6.3.2.1. Injectable Drug Delivery System
  - 6.3.2.2. Injectable Devices
- 6.3.3. Transdermal Drug Delivery System
- 6.3.4. Inhalation Drug Delivery System
- 6.3.5. Implantable Drug Delivery System
- 6.3.6. Others
6.4. Market Attractiveness By Type

7. Global Drug Delivery Systems Market Analysis and Forecasts, By Application

7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Application, 2020-2035
- 7.3.1. Oncological Disorders
- 7.3.2. Infectious Diseases
- 7.3.3. Respiratory Disorders
- 7.3.4. Cardiovascular Disorders
- 7.3.5. Autoimmune Disorders
- 7.3.6. CNS Disorders
- 7.3.7. Others
7.4. Market Attractiveness By Application

8. Global Drug Delivery Systems Market Analysis and Forecasts, By End-user

8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By End-user, 2020-2035
- 8.3.1. Hospitals
- 8.3.2. Ambulatory Surgical Centers
- 8.3.3. Homecare Settings
- 8.3.4. Others
8.4. Market Attractiveness By End-user

9. Global Drug Delivery Systems Market Analysis and Forecasts, By Region

9.1. Key Findings
9.2. Market Value Forecast By Region
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
9.3. Market Attractiveness By Region

10. North America Drug Delivery Systems Market Analysis and Forecast

10.1. Introduction
- 10.1.1. Key Findings
10.2. Market Value Forecast By Type, 2020-2035
- 10.2.1. Oral Drug Delivery System
  - 10.2.1.1. Controlled-release Drug Delivery
  - 10.2.1.2. Other Oral Drug Delivery
- 10.2.2. Injection-based Drug Delivery System
  - 10.2.2.1. Injectable Drug Delivery System
  - 10.2.2.2. Injectable Devices
- 10.2.3. Transdermal Drug Delivery System
- 10.2.4. Inhalation Drug Delivery System
- 10.2.5. Implantable Drug Delivery System
- 10.2.6. Others
10.3. Market Value Forecast By Application, 2020-2035
- 10.3.1. Oncological Disorders
- 10.3.2. Infectious Diseases
- 10.3.3. Respiratory Disorders
- 10.3.4. Cardiovascular Disorders
- 10.3.5. Autoimmune Disorders
- 10.3.6. CNS Disorders
- 10.3.7. Others
10.4. Market Value Forecast By End-user, 2020-2035
- 10.4.1. Hospitals
- 10.4.2. Ambulatory Surgical Centers
- 10.4.3. Homecare Settings
- 10.4.4. Others
10.5. Market Value Forecast By Country, 2020-2035
- 10.5.1. U.S.
- 10.5.2. Canada
10.6. Market Attractiveness Analysis
- 10.6.1. By Type
- 10.6.2. By Application
- 10.6.3. By End-user
- 10.6.4. By Country

11. Europe Drug Delivery Systems Market Analysis and Forecast

11.1. Introduction
- 11.1.1. Key Findings
11.2. Market Value Forecast By Type, 2020-2035
- 11.2.1. Oral Drug Delivery System
  - 11.2.1.1. Controlled-release Drug Delivery
  - 11.2.1.2. Other Oral Drug Delivery
- 11.2.2. Injection-based Drug Delivery System
  - 11.2.2.1. Injectable Drug Delivery System
  - 11.2.2.2. Injectable Devices
- 11.2.3. Transdermal Drug Delivery System
- 11.2.4. Inhalation Drug Delivery System
- 11.2.5. Implantable Drug Delivery System
- 11.2.6. Others
11.3. Market Value Forecast By Application, 2020-2035
- 11.3.1. Oncological Disorders
- 11.3.2. Infectious Diseases
- 11.3.3. Respiratory Disorders
- 11.3.4. Cardiovascular Disorders
- 11.3.5. Autoimmune Disorders
- 11.3.6. CNS Disorders
- 11.3.7. Others
11.4. Market Value Forecast By End-user, 2020-2035
- 11.4.1. Hospitals
- 11.4.2. Ambulatory Surgical Centers
- 11.4.3. Homecare Settings
- 11.4.4. Others
11.5. Market Value Forecast By Country / Sub-region, 2020-2035
- 11.5.1. Germany
- 11.5.2. U.K.
- 11.5.3. France
- 11.5.4. Spain
- 11.5.5. Italy
- 11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
- 11.6.1. By Type
- 11.6.2. By Application
- 11.6.3. By End-user
- 11.6.4. By Country / Sub-region

12. Asia Pacific Drug Delivery Systems Market Analysis and Forecast

12.1. Introduction
- 12.1.1. Key Findings
12.2. Market Value Forecast By Type, 2020-2035
- 12.2.1. Oral Drug Delivery System
  - 12.2.1.1. Controlled-release Drug Delivery
  - 12.2.1.2. Other Oral Drug Delivery
- 12.2.2. Injection-based Drug Delivery System
  - 12.2.2.1. Injectable Drug Delivery System
  - 12.2.2.2. Injectable Devices
- 12.2.3. Transdermal Drug Delivery System
- 12.2.4. Inhalation Drug Delivery System
- 12.2.5. Implantable Drug Delivery System
- 12.2.6. Others
12.3. Market Value Forecast By Application, 2020-2035
- 12.3.1. Oncological Disorders
- 12.3.2. Infectious Diseases
- 12.3.3. Respiratory Disorders
- 12.3.4. Cardiovascular Disorders
- 12.3.5. Autoimmune Disorders
- 12.3.6. CNS Disorders
- 12.3.7. Others
12.4. Market Value Forecast By End-user, 2020-2035
- 12.4.1. Hospitals
- 12.4.2. Ambulatory Surgical Centers
- 12.4.3. Homecare Settings
- 12.4.4. Others
12.5. Market Value Forecast By Country / Sub-region, 2020-2035
- 12.5.1. China
- 12.5.2. Japan
- 12.5.3. India
- 12.5.4. Australia & New Zealand
- 12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
- 12.6.1. By Type
- 12.6.2. By Application
- 12.6.3. By End-user
- 12.6.4. By Country / Sub-region

13. Latin America Drug Delivery Systems Market Analysis and Forecast

13.1. Introduction
- 13.1.1. Key Findings
13.2. Market Value Forecast By Type, 2020-2035
- 13.2.1. Oral Drug Delivery System
  - 13.2.1.1. Controlled-release Drug Delivery
  - 13.2.1.2. Other Oral Drug Delivery
- 13.2.2. Injection-based Drug Delivery System
  - 13.2.2.1. Injectable Drug Delivery System
  - 13.2.2.2. Injectable Devices
- 13.2.3. Transdermal Drug Delivery System
- 13.2.4. Inhalation Drug Delivery System
- 13.2.5. Implantable Drug Delivery System
- 13.2.6. Others
13.3. Market Value Forecast By Application, 2020-2035
- 13.3.1. Oncological Disorders
- 13.3.2. Infectious Diseases
- 13.3.3. Respiratory Disorders
- 13.3.4. Cardiovascular Disorders
- 13.3.5. Autoimmune Disorders
- 13.3.6. CNS Disorders
- 13.3.7. Others
13.4. Market Value Forecast By End-user, 2020-2035
- 13.4.1. Hospitals
- 13.4.2. Ambulatory Surgical Centers
- 13.4.3. Homecare Settings
- 13.4.4. Others
13.5. Market Value Forecast By Country / Sub-region, 2020-2035
- 13.5.1. Brazil
- 13.5.2. Mexico
- 13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
- 13.6.1. By Type
- 13.6.2. By Application
- 13.6.3. By End-user
- 13.6.4. By Country / Sub-region

14. Middle East & Africa Drug Delivery Systems Market Analysis and Forecast

14.1. Introduction
- 14.1.1. Key Findings
14.2. Market Value Forecast By Type, 2020-2035
- 14.2.1. Oral Drug Delivery System
  - 14.2.1.1. Controlled-release Drug Delivery
  - 14.2.1.2. Other Oral Drug Delivery
- 14.2.2. Injection-based Drug Delivery System
  - 14.2.2.1. Injectable Drug Delivery System
  - 14.2.2.2. Injectable Devices
- 14.2.3. Transdermal Drug Delivery System
- 14.2.4. Inhalation Drug Delivery System
- 14.2.5. Implantable Drug Delivery System
- 14.2.6. Others
14.3. Market Value Forecast By Application, 2020-2035
- 14.3.1. Oncological Disorders
- 14.3.2. Infectious Diseases
- 14.3.3. Respiratory Disorders
- 14.3.4. Cardiovascular Disorders
- 14.3.5. Autoimmune Disorders
- 14.3.6. CNS Disorders
- 14.3.7. Others
14.4. Market Value Forecast By End-user, 2020-2035
- 14.4.1. Hospitals
- 14.4.2. Ambulatory Surgical Centers
- 14.4.3. Homecare Settings
- 14.4.4. Others
14.5. Market Value Forecast By Country / Sub-region, 2020-2035
- 14.5.1. GCC Countries
- 14.5.2. South Africa
- 14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
- 14.6.1. By Type
- 14.6.2. By Application
- 14.6.3. By End-user
- 14.6.4. By Country / Sub-region

15. Competition Landscape

15.1. Market Player - Competition Matrix (By Tier and Size of companies)
15.2. Company Market Share Analysis (2024)
15.3. Company Profiles
- 15.3.1. Becton, Dickinson and Company
  - 15.3.1.1. Company Overview
  - 15.3.1.2. Financial Overview
  - 15.3.1.3. Product Portfolio
  - 15.3.1.4. Business Strategies
  - 15.3.1.5. Recent Developments
- 15.3.2. B. Braun Melsungen AG
  - 15.3.2.1. Company Overview
  - 15.3.2.2. Financial Overview
  - 15.3.2.3. Product Portfolio
  - 15.3.2.4. Business Strategies
  - 15.3.2.5. Recent Developments
- 15.3.3. Terumo Medical Corporation
  - 15.3.3.1. Company Overview
  - 15.3.3.2. Financial Overview
  - 15.3.3.3. Product Portfolio
  - 15.3.3.4. Business Strategies
  - 15.3.3.5. Recent Developments
- 15.3.4. Medtronic plc
  - 15.3.4.1. Company Overview
  - 15.3.4.2. Financial Overview
  - 15.3.4.3. Product Portfolio
  - 15.3.4.4. Business Strategies
  - 15.3.4.5. Recent Developments
- 15.3.5. Koninklijke Philips N.V.
  - 15.3.5.1. Company Overview
  - 15.3.5.2. Financial Overview
  - 15.3.5.3. Product Portfolio
  - 15.3.5.4. Business Strategies
  - 15.3.5.5. Recent Developments
- 15.3.6. Baxter International Inc.
  - 15.3.6.1. Company Overview
  - 15.3.6.2. Financial Overview
  - 15.3.6.3. Product Portfolio
  - 15.3.6.4. Business Strategies
  - 15.3.6.5. Recent Developments
- 15.3.7. Pfizer Inc.
  - 15.3.7.1. Company Overview
  - 15.3.7.2. Financial Overview
  - 15.3.7.3. Product Portfolio
  - 15.3.7.4. Business Strategies
  - 15.3.7.5. Recent Developments
- 15.3.8. Teva Pharmaceutical Industries Ltd.
  - 15.3.8.1. Company Overview
  - 15.3.8.2. Financial Overview
  - 15.3.8.3. Product Portfolio
  - 15.3.8.4. Business Strategies
  - 15.3.8.5. Recent Developments
- 15.3.9. Teleflex Incorporated
  - 15.3.9.1. Company Overview
  - 15.3.9.2. Financial Overview
  - 15.3.9.3. Product Portfolio
  - 15.3.9.4. Business Strategies
  - 15.3.9.5. Recent Developments
- 15.3.10. Novartis AG
  - 15.3.10.1. Company Overview
  - 15.3.10.2. Financial Overview
  - 15.3.10.3. Product Portfolio
  - 15.3.10.4. Business Strategies
  - 15.3.10.5. Recent Developments
- 15.3.11. Gerresheimer AG
  - 15.3.11.1. Company Overview
  - 15.3.11.2. Financial Overview
  - 15.3.11.3. Product Portfolio
  - 15.3.11.4. Business Strategies
  - 15.3.11.5. Recent Developments
- 15.3.12. Abbott
  - 15.3.12.1. Company Overview
  - 15.3.12.2. Financial Overview
  - 15.3.12.3. Product Portfolio
  - 15.3.12.4. Business Strategies
  - 15.3.12.5. Recent Developments
- 15.3.13. Ypsomed AG
  - 15.3.13.1. Company Overview
  - 15.3.13.2. Financial Overview
  - 15.3.13.3. Product Portfolio
  - 15.3.13.4. Business Strategies
  - 15.3.13.5. Recent Developments
- 15.3.14. SHL Medical
  - 15.3.14.1. Company Overview
  - 15.3.14.2. Financial Overview
  - 15.3.14.3. Product Portfolio
  - 15.3.14.4. Business Strategies
  - 15.3.14.5. Recent Developments
- 15.3.15. Owen Mumford
  - 15.3.15.1. Company Overview
  - 15.3.15.2. Financial Overview
  - 15.3.15.3. Product Portfolio
  - 15.3.15.4. Business Strategies
  - 15.3.15.5. Recent Developments